静脉输液市场：市场规模、份额、前景、按解决方案、输液袋类型、应用、最终用户和地区分類的机会分析，2025 年至 2032 年

2025 年全球静脉输液市场规模估计为 110.5 亿美元，预计到 2032 年将达到 169.5 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 6.3%。

数字。 2025年静脉注射液市场占有率（按地区划分）

静脉注射液是直接注射到静脉循环的液体。这些液体是无菌、无热原的溶液，包装在单剂量容器中，用于静脉注射以提供水分和热量补充。市面上有各种类型的静脉注射液，例如氯化钠、乳酸林格氏液和葡萄糖水溶液。对于营养不良和脱水的患者来说，静脉注射疗法是理想的选择。脱水会产生多种影响，包括：

• 体内重要矿物质（电解质）的平衡。
• 认知（心理）能力
• 能量水平
• 胃肠功能（消化食物和产生尿液和粪便的能力）
• 头痛的频率和强度
• 体能
• 皮肤健康

市场动态

预计预测期内腹泻病患病率的不断上升将推动全球静脉输液市场的成长。例如，2022年7月，为全球儿童提供人道和发展援助的联合国机构联合国儿童基金会（UNICEF）发布报告指出，2020年全球五岁以下儿童死亡总数中，腹泻占9%，而每天有超过1300名婴儿因腹泻死亡，导致全球整体每年约有48.4万名儿童死亡。

此外，根据2018年9月发表在《柳叶刀传染病》上的一篇论文，腹泻是2016年导致伤残调整生命年（DALY）的第三大原因，占全球整体DALY的7440万。根据同一来源，腹泻是第八大死因，2016 年全球整体造成 1,655,944 人死亡。

本研究的主要特点

• 本报告对全球静脉注射溶液市场进行了详细分析，预测期为 2025 年至 2032 年，以 2024 年为基准年。
• 它揭示了各个领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
• 它根据公司概况、财务表现、产品系列、地理位置、分销策略、关键发展和策略等参数，介绍了全球输液解决方案市场的主要企业概况。
• 本报告的见解将帮助企业负责人和经营团队就未来的产品发布、政府措施、技术改进、市场扩张和行销策略做出明智的决策。
• 本研究报告针对该产业的各个相关人员，包括投资者、产品製造商、经销商、相关人员、研究公司、顾问公司、新参与企业和财务分析师。
• 相关人员可以透过用于分析全球静脉输液市场的各种策略矩阵来促进他们的决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
  • 限制因素
  • 市场机会
• 影响分析
• 市场趋势
• 主要进展
• 流行病学
• 波特五力分析

4. 全球静脉注射解决方案市场-冠状病毒（COVID-19）大流行的影响

• 整体影响
• COVID-19 市场影响

5. 2020 年至 2032 年全球静脉注射解决方案市场（按解决方案划分）

• 生理食盐水
• 生理食盐水（0.9％NaCl）
• 高渗透压盐水
• 聚葡萄糖
• 乳酸林格氏液
• 胺基酸
• 维生素和矿物质
• 肝素和微量元素
• 混合解决方案

6. 2020 年至 2032 年全球静脉注射液市场（依袋型）

• 大容量包（250ml以上）
• 小容量袋（小于250毫升）

7. 2020 年至 2032 年全球静脉注射解决方案市场（按应用）

• 基本静脉注射解决方案
• 营养滴注
• 输血
• 药物输注
• 灌溉静脉注射液

8. 2020 年至 2032 年全球静脉注射解决方案市场（依最终使用者划分）

• 医院
• 诊所
• 门诊手术中心
• 家庭护理设置

9. 2020 年至 2032 年全球静脉注射解决方案市场（按地区）

• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第十章 竞争格局

• 热图分析
• 公司简介
  • Baxter International Inc.
  • ICU Medical, Inc.
  • B. Braun Melsungen Ag
  • Grifols, SA
  • Fresenius Kabi USA, LLC
  • Vifor Pharma Management Ltd.
  • JW Life Science
  • Amanta Healthcare
  • Axa Parenterals Ltd
  • Salius Pharma Private Limited.
  • Pfizer, Inc.
  • Otsuka Pharmaceutical Co., Ltd
  • Ajinomoto Co., Inc.
  • Braun Melsungen AG
  • Soxa Formulations &Research Pvt. Ltd
  • Sichuan Kelun Pharmaceutical Co Ltd

第 11 章分析师建议

• 命运之轮
• 分析师观点
• 一致的机会图

第十二章 章节

• 参考
• 调查方法

Global Intravenous Solutions Market is estimated to be valued at USD 11.05 Bn in 2025 and is expected to reach USD 16.95 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.3% from 2025 to 2032.

Figure. Intravenous Solutions Market Share (%), By Region 2025

Intravenous solutions are fluids, which are administrated to a patient directly into the venous circulation. These fluids are sterile, non-pyrogenic solutions used for fluid replenishment and caloric supply in single dose container for intravenous administration. There are various types of intravenous solutions available in the market such as sodium chloride, lactated ringers, dextrose in water, and others. Intravenous therapy is ideal for patients suffering from nutritional deficiency and dehydration. Dehydration can contribute to various affects such as

• Balance of important minerals (electrolytes) in the body.
• Cognitive (mental) performance.
• Energy level.
• Gastrointestinal function (your ability to digest food and create pee and poop).
• Headache frequency and intensity.
• Physical performance.
• Skin health.

Market Dynamics

Increasing prevalence of diarrhoea is expected to boost the global intravenous solution market growth over the forecast period. For instance, in July 2022, UNICEF (United Nations International Children's Emergency Fund), an agency of the United Nations responsible for providing humanitarian and developmental aid to children worldwide, published a report which accounted for 9 per cent of all deaths among children under age 5 worldwide in 2020 due to Diarrhoea, whereas over 1,300 young children dying each day, or about 484,000 children a year globally due to diarrhoea.

Moreover, according to an article published in the Lancet Infectious Diseases, September 2018, diarrhoea was the third leading cause of disability-adjusted life year (DALYs) in 2016, which accounted for 74.4 million DALYs, globally. According to the same source, diarrhoea was the eighth leading cause of death, which accounted for 1,655,944 deaths in 2016 globally.

Key features of the study:

• This report provides an in-depth analysis of the global intravenous solutions market, market size (US$ Bn), and compound annual growth rate (CAGR (%)) for the forecast period: 2025 - 2032, considering 2024 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles key players in the global intravenous solutions market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include, Baxter International Inc. ICU Medical, Inc, B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, Axa Parenterals Ltd, and Salius Pharma Private Limited, Pfizer, Inc, Otsuka Pharmaceutical Co., Ltd, Ajinomoto Co., Inc., B. Braun Melsungen AG, Soxa Formulations & Research Pvt.Ltd, Sichuan Kelun Pharmaceutical Co Ltd.
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global intravenous solutions market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, suppliers, research and consulting firms, new entrants, and financial analysts
• Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global intravenous solutions market.

Detailed Segmentation:

• Global Intravenous Solutions Market, By Solution type:
  • Saline
  • Normal Saline (0.9% NaCl)
  • Hypertonic Saline
  • Dextran
  • Lactated Ringer's
  • Amino Acid
  • Vitamins & Minerals
  • Heparin and Trace Elements
  • Mixed Solutions
• Global Intravenous Solutions Market, By Bag type:
  • Large Volume Bags (greater than 250ml)
  • Small Volume Bags (less than 250ml)
• Global Intravenous Solutions Market, By Application:
  • Basic IV Solution
  • Nutritional IV Solution
  • Blood IV Solution
  • Drug IV Solution
  • Irrigation IV Solution
• Global Intravenous Solutions Market, By End User:
  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers
  • Home Care Settings
• Global Intravenous Solutions Market, By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • Baxter International Inc.
  • ICU Medical, Inc.
  • Braun Melsungen Ag
  • Grifols, S.A.
  • Fresenius Kabi USA, LLC
  • Vifor Pharma Management Ltd.
  • JW Life Science
  • Amanta Healthcare
  • Axa Parenterals Ltd.
  • Salius Pharma Private Limited.
  • Pfizer, Inc.
  • Otsuka Pharmaceutical Co., Ltd
  • Ajinomoto Co., Inc.
  • Braun Melsungen AG
  • Soxa Formulations & Research Pvt.Ltd
  • Sichuan Kelun Pharmaceutical Co Ltd

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Solution
  • Market Snapshot, By Bag Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Epidemiology
• Porter's Five Forces Analysis

4. Global Intravenous Solutions Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• COVID-19 Impact on the market

5. Global Intravenous Solutions Market, By Solution, 2020 - 2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Saline
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Normal Saline (0.9% NaCl)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Hypertonic Saline
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Dextran
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Lactated Ringer's
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Amino Acid
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Vitamins & Minerals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Heparin and trace elements
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Mixed Solutions
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

6. Global Intravenous Solutions Market, By Bag Type, 2020 - 2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Large Volume Bags (greater than 250ml)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Small Volume Bags (less than 250ml)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Global Intravenous Solutions Market, By Application, 2020 - 2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Basic IV Solution
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Nutritional IV Solution
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Blood IV Solution
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Drug IV Solution
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Irrigation IV Solution
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

8. Global Intravenous Solutions Market, By End User, 2020 - 2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Ambulatory Surgery Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Home care Settings
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

9. Global Intravenous Solutions Market, By Region, 2020 - 2032, (US$ Billion)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Regions, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (US$ Billion)
    • North Africa
    • Central Africa
    • South Africa

10. Competitive Landscape

• Heat Map Analysis
• Company Profile
  • Baxter International Inc.
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • ICU Medical, Inc.
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • B. Braun Melsungen Ag
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Grifols, S.A
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Fresenius Kabi USA, LLC
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Vifor Pharma Management Ltd.
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • JW Life Science
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Amanta Healthcare
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Axa Parenterals Ltd
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Salius Pharma Private Limited.
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Pfizer, Inc.
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Otsuka Pharmaceutical Co., Ltd
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Ajinomoto Co., Inc.
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Braun Melsungen AG
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Soxa Formulations & Research Pvt. Ltd
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Sichuan Kelun Pharmaceutical Co Ltd
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies

11. Analyst Recommendation

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. Section

• References
• Research Methodology
• About Us and Sales Contact